Tag Archives: psychiatry

Treating Depression: Personalized Deep Brain Stimulation

How would you feel if the treatment or medication you were taking had little to no effect in suppressing your symptoms? Unfortunately, this is the case for 1 in 3 patients diagnosed with depression. These patients fall under a category known as treatment-resistant depression. Personalized deep brain stimulation, a promising alternative to conventional treatments, has the potential to treat various forms of depression by allowing physicians to tailor treatment to an individual.

THE PROBLEM

Depression, which is characterized by low mood, is linked to an imbalance of serotonin, norepinephrine, and dopamine neurotransmitters in the brain. It is a common mental illness that affects the way someone feels, thinks, and acts. However, it is important to note that depression varies significantly among individuals and many other factors play a role.

Source: flickr.com

As stated by Ben Paul from USC Viterbi School of Engineering,

“Mental disorders can manifest differently in each patient’s brain.”

There is no single treatment that can effectively treat the symptoms of depression among all diagnosed individuals. This makes it hard for physicians to provide the best treatment for their patients.

WHAT IS DEEP BRAIN STIMULATION?

Deep brain stimulation (DBS) is a surgical procedure where electrodes are implanted within specific areas of the brain. By electrically stimulating these parts of the brain, physicians can reduce the symptoms associated with depression. The amount of stimulation is controlled by a pacemaker that is placed under the skin on the chest.

The video below explains this procedure further and contains an interview with Edi Guyton, a patient who had this surgery: 

Source: CNN | Youtube

PROMISING ALTERNATIVE: PERSONALIZED DEEP BRAIN STIMULATION 

Even with deep brain stimulation, each patient’s response to treatment will be different. However, one of the pros of deep brain stimulation is that it results in immediate changes. This is the key component that allows physicians to personalize treatment. A 2021 research study led by Dr. Maryam Shanechi and her team at the USC Viterbi School of Engineering explains an approach that can be used to predict and see how an individual’s brain responds to stimulation. Her research will allow physicians to monitor brain regions in real-time.

How is this done? 

       Two tools have been designed: 

  1. Electrical stimulation wave to map brain activity
  2. Machine-learning techniques that can learn the mapped brain activity which is collected during stimulation 

The stimulation wave tool randomly changes the characteristics (amplitude and frequency) of the electrical impulse over time. A change in these characteristics is the equivalent of changing the dosage of a medication. Analysis of brain activity during these changes will help physicians determine the correct stimulation doses. 

THE FUTURE: TREATING DEPRESSION

Dr. Maryam Shanechi’s research will allow physicians to personalize deep brain stimulation for all patients diagnosed with depression. This can help physicians overcome the difficulty of assisting individuals with treatment-resistant depression. Success within this field of personalized deep brain stimulation not only holds great potential for treating depression but can also lead to improved treatments for other psychiatric disorders. 

Source: flickr.com

 

– Samantha Nalliah

From Recreational to Pharmaceutical – A Promising Psychedelic in Research

Current research on the use of psychedelic drugs for therapeutic applications is showing a lot of promise, building on the potential first demonstrated by studies  conducted in the 1950’s. Humphry Osmond, the psychiatrist who coined the term “psychedelics”, is considered one of the pioneers of psychedelics research. He believed hallucinogenic drugs could be used to treat mental illnesses, and his research findings supported his beliefs. His study on the use of LSD to treat alcoholism found that at the one year follow-up, almost half of study participants who suffered from alcoholism didn’t return to drinking. As such, Osmond’s seminal studies paved the path for the emerging field of psychedelics research. Fast-forward to today, research studies are demonstrating that under controlled conditions, psychedelic drugs like LSD, psilocybin (the active compound in magic mushrooms), and ketamine hold the potential for treating an array of mental illnesses – from alcoholism, to PTSD, to depression, anxiety, and OCD.  As the newest addition, MDMA is joining the rest of its peers in psychedelics research and may hold great potential.

Humphry Osmond, Source: Jeremy Leung

MDMA, otherwise known as ecstasy, E, M, or Molly, is an infamous psychoactive drug often associated with nightclub and rave scenes. Hours of partying are fueled by intense feelings of pleasure, emotional warmth, and an abundance of energy owed to this little pill with so many names. The negative stigma attached to recreational drug use has given MDMA a bad rep, but research studies from an organization called Multidisciplinary Association for Psychedelics Studies (MAPS) are challenging these stigmatized views.

A team of MAPS researchers in California are repurposing MDMA to treat the psychological distress experienced by people suffering from life-threatening illnesses (LTI). People living with, or that have lived with an LTI can experience anxiety, depression, anger, and despair associated with their traumatic experiences. In one of the first clinical trials of its kind, Dr. Philip Wolfson and his team explored how using MDMA during psychotherapy sessions impacted participant’s distress levels. The team found that the study participants who took MDMA had improved mindfulness and a more positive outlook towards their traumatic experiences. Also, depression, sleep quality, and anxiety levels  improved, but these improvements couldn’t conclusively be attributed to the MDMA. The findings of this pilot study suggest MDMA could still have the potential to reduce psychological distress associated with LTI and that it may also have positive long-term effects.

Although current studies like Dr. Wolfson’s show promising results, could the stigma surrounding “hard drugs” like MDMA deter patients from taking them once/if they become approved for clinical use? Or would the existing stigma dwindle once they get a doctor’s stamp of approval? Or maybe it’s simply why the drugs are used that give recreational use a bad name. Whatever your beliefs and convictions, scientifically, “hard drugs” may have a place in medicine in the (potentially near) future.

Source: GoodRx.com

By Maya Bird

Treating Depression: Personalized Deep Brain Stimulation

Source: flickr.com

How would you feel if the treatment or medication you were taking had little to no effect in suppressing your symptoms? Unfortunately, this is the case for 1 in 3 patients diagnosed with depression. These patients fall under a category known as treatment-resistant depression. Personalized deep brain stimulation, a promising alternative to conventional treatments, has the potential to solve this problem by allowing physicians to tailor treatments to an individual’s needs.

The Problem

Depression, which is characterized by low mood, is linked to an imbalance of serotonin, norepinephrine, and dopamine neurotransmitters in the brain. It is a common mental illness that affects the way someone feels, thinks, and acts. However, it is important to note that depression varies significantly among individuals and many other factors play a role. As stated by Ben Paul from USC Viterbi School of Engineering,

“Mental disorders can manifest differently in each patient’s brain.”

There is no one single treatment that is able to effectively treat the symptoms of depression among all diagnosed individuals. This makes it hard for physicians to provide the best treatment for their patients.

What is deep brain stimulation?

Deep brain stimulation (DBS) is a surgical procedure where electrodes are implanted within specific areas of the brain. By electrically stimulating these parts of the brain, physicians can reduce the symptoms associated with depression. The amount of stimulation is controlled by a pacemaker that is placed under skin on the chest.

The video below explains this procedure further and contains an interview with Edi Guyton, a patient who had this surgery: 

Source: CNN | Youtube

Promising Alternative: Personalized Deep Brain Stimulation 

Even with deep brain stimulation, each patient’s response to treatment will be different. However, one of the pros of deep brain stimulation is that it results in immediate changes. This is the key component that allows physicians to personalize treatment.

Research led by Maryam Shanechi and her team at USC Viterbi School of Engineering have figured out a way to predict and see how an individual’s brain responds to stimulation. This allows physicians to monitor brain regions in real time.

How is this done? 

           Two tools have been designed: 

  1. Electrical stimulation wave to map brain activity
  2. Machine-learning techniques that are able to learn the mapped brain activity which is collected during stimulation 

The stimulation wave designed by Maryam and her team randomly changes amplitude and frequency of the electrical impulse over time. A change in amplitude and frequency would be the equivalent to changing the milligram dose of a pill. Analysis of brain activity during these changes will allow physicians to arrive at the correct stimulation doses.  As a result, physicians will be able to personalize and tailor the deep brain stimulation for the individual. 

This treatment can be used to find an effective approach for almost all patients diagnosed with depression.  Success within this field of personalized deep brain stimulation will hopefully lead to more application for other mental disorders. 

– Samantha Nalliah

 

 

From Recreational to Pharmaceutical – Promising Party Drugs in Research

Source: Unsplash.com

3,4-Methylenedioxymethamphetamine, more commonly known as MDMA, ecstasy, E, M, or Molly, is an infamous psychoactive drug often associated with nightclub and rave scenes. Hours of partying are fueled by intense feelings of pleasure, emotional warmth, and an abundance of energy owed to this little pill with so many names. The negative stigma attached to recreational drug use has given MDMA a bad rep, but a team of researchers in California are repurposing this synthetic drug to treat anxiety in people suffering from life-threatening illnesses (LTI).

In one of the first clinical trials of its kind, Dr. Philip Wolfson and his team explored how using MDMA during psychotherapy sessions impacted anxiety levels. The team found that the study participants who took MDMA had improved mindfulness and a more positive outlook towards their traumatic experiences. Depression, sleep quality, and anxiety levels also improved, but these improvements couldn’t conclusively be attributed to the MDMA. The findings of this small pilot study suggest MDMA could still have potential to reduce anxiety associated with LTI and may also have positive long-term effects.

MDMA is only one of many drugs currently being researched for therapeutic applications. LSD, famously tested for mind control by the CIA in the 1950’s and 60’s as a part of the MK-ULTRA Program, shows potential for treating alcoholism and could also treat PTSD. Another psychedelic drug called psilocybin, the active compound in magic mushrooms, is being investigated to treat a myriad of mental health disorders: from depression, to anxiety, to OCD, to certain substance use disorders. A horse tranquillizer called ketamine, which doubles as a club drug, is being researched to treat depression and (so far) shows potential.

Although current studies show promising results, could the stigma surrounding hard drugs like MDMA and ketamine deter patients from taking them once/if they become approved for clinical use? Or would the existing stigma dwindle once they get a doctor’s stamp of approval? Or maybe it’s simply why the drugs are used that give recreational use a bad name. Whatever your beliefs and convictions, scientifically, hard drugs may have a place in medicine in the (potentially near) future.

Source: GoodRx.com

By Maya Bird